CRXL: Summary for Crucell NV - Yahoo! Canada Finance - Share Prices, Charts, News and more

MORE ON CRXL

Quotes

Summary

Charts

News & Info

Company

Analyst Coverage

Ownership

Financials

Crucell NV (NasdaqNM:CRXL) Delayed quote data

Last Trade:	19.59 USD
Trade Time:	Feb 9
Change:	0.00 (0.00%)
Prev Close:	19.59
Open:	N/A
Bid:	19.35 x 900
Ask:	19.41 x 900
1y Target Est:	18.64

Day's Range:	N/A - N/A
52wk Range:	17.50 - 25.53
Volume:	0
Avg Vol (3m):	89,882.5
Market Cap:	N/A
P/E (ttm):	N/A
EPS (ttm):	N/A
Div & Yield:	N/A (N/A%)

1d 5d 3m 6m 1y 2y 5y max

Free Annual Reports

Add CRXL to Portfolio

Download Data

HEADLINES

•	Crucell N.V. ADS Q4 2009 Earnings Call Transcript
	at Seeking Alpha (Tue 11:58am)

•	UPDATE - Crucell seeking new growth engine, to boost R&D
	at Reuters (Tue 8:01am)

•	Q4 2009 Crucell Earnings Release - Time Not Supplied
	CCBN (Tue 7:07am)

•	Crucell Announces Record Revenues and Profits for Full Year 2009
	Marketwire (Tue 2:17am)

•	Big Pharma's Shot In The Arm
	at CNBC (Fri, Feb 5)

•	Crucell to Release Fourth Quarter and Full Year 2009 Results on Tuesday February 9, 2010
	Marketwire (Tue, Feb 2)

•	Is the Best of Johnson & Johnson Behind It?
	at Motley Fool (Tue, Jan 26)

•	Zacks #5 Rank Additions for Tuesday
	Zacks.com (Tue, Jan 19)

•	Crucell N.V. downgraded by Jefferies & Co
	Briefing.com (Tue, Jan 12)

•	Vaccines on horizon for AIDS, Alzheimer's, herpes
	AP (Wed, Nov 18)

•	Vaccines on horizon for AIDS, Alzheimer's, herpes
	AP (Tue, Nov 17)

More Headlines for CRXL...

ANALYST

EPS Est (next year) (Dec-09) :	0.23
EPS Est (in 2 years) (Dec-10) :	0.62
Avg Rec (current)*:	3.0
PEG Ratio:	3.96

* (Strong Buy) 1.0 - 5.0 (Strong Sell)

Analyst Opinion - Estimates

BUSINESS SUMMARY

No business summary available for CRXL.

Add to Portfolio

Email to a Friend

•

	Sign In [New User? Sign Up]	Finance Home \|Help

Crucell NV (CRXL)